Brain Circuits Encoding Reward from Pain Relief

Trends in Neurosciences

Volumn 38, Issue 11, 2015, Pages 741-750

  Navratilova, Edita ^a   Atcherley, Christopher W ^b   Porreca, Frank ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; ENDORPHIN; FLUPENTIXOL; MORPHINE; OPIATE; TRACER;

ANALGESIA; ANTERIOR CINGULATE; ASSOCIATION; BOLD SIGNAL; BRAIN REGION; CELL ACTIVATION; CHRONIC PAIN; COGNITION; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LEARNING; MESENCEPHALON; MOTIVATION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; NUCLEUS ACCUMBENS; NUCLEUS ACCUMBENS SHELL; PAIN INTENSITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REINFORCEMENT; REVIEW; REWARD; SIGNAL TRANSDUCTION; STATE DEPENDENT LEARNING; TASK PERFORMANCE; VENTRAL TEGMENTUM; ANIMAL; METABOLISM; NERVE CELL NETWORK; PAIN; PATHOPHYSIOLOGY;

ANALGESIA; ANIMALS; DOPAMINE; HUMANS; NERVE NET; PAIN; PAIN MANAGEMENT; REWARD;

EID: 84947738968     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2015.09.003     Document Type: Review

References (88)

1. Woolf C.J., Ma Q. Nociceptors - noxious stimulus detectors. Neuron 2007, 55:353.
2. Basbaum A.I., et al. Cellular and molecular mechanisms of pain. Cell 2009, 139:267.
3. Fields H.L. Pain: an unpleasant topic. Pain 1999, 6(Suppl.):S61.
4. Leknes S., et al. Pain relief as an opponent process: a psychophysical investigation. Eur. J. Neurosci. 2008, 28:794.
5. Leknes S., et al. Relief as a reward: hedonic and neural responses to safety from pain. PLoS ONE 2001, 6:e17870.
6. Seminowicz D.A., et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J. Neurosci. 2011, 31:7540.
7. Tracey I., Bushnell M.C. How neuroimaging studies have challenged us to rethink: is chronic pain a disease?. J. Pain 2009, 10:1113.
8. Wood P., et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 2007, 25:3576.
9. Percie du Sert N., Rice A.S. Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain. Br. J. Pharmacol. 2014, 171:2951.
10. Apkarian A.V., et al. Predicting transition to chronic pain. Curr. Opin. Neurol. 2013, 26:360.
11. Martikainen I.K., et al. Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum. J. Neurosci. 2015, 35:9957.
12. Navratilova E., Porreca F. Reward and motivation in pain and pain relief. Nat. Neurosci. 2014, 17:1304.
13. Bromberg-Martin E.S., et al. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815.
14. Schultz W. Updating dopamine reward signals. Curr. Opin. Neurobiol. 2013, 23:229.
15. Lammel S., et al. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 2014, 76:351.
16. Ungless M.A. Dopamine: the salient issue. Trends Neurosci. 2004, 27:702.
17. Redgrave P., et al. What is reinforced by phasic dopamine signals?. Brain Res. Rev. 2008, 58:322.
18. Matsumoto M., Hikosaka O. Two types of dopamine neuron distinctly convey positive and negative motivational signals. Nature 2009, 459:837.
19. Mileykovskiy B., Morales M. Duration of inhibition of ventral tegmental area dopamine neurons encodes a level of conditioned fear. J. Neurosci. 2011, 31:7471.
20. Cohen J.Y., et al. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 2012, 482:85.
21. Zweifel L.S., et al. Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat. Neurosci. 2011, 14:620.
22. Brischoux F., et al. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4894.
23. Coizet V., et al. Nociceptive responses of midbrain dopaminergic neurones are modulated by the superior colliculus in the rat. Neuroscience 2006, 139:1479.
24. Grace A.A., et al. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 2007, 30:220.
25. Zweifel L.S., et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7281.
26. Tsai H.C., et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009, 324:1080.
27. Klitenick M.A., et al. Effects of chronic haloperidol on stress- and stimulation-induced increases in dopamine release: tests of the depolarization block hypothesis. Neuropsychopharmacology 1996, 15:424.
28. Rouge-Pont F., et al. Individual differences in stress-induced dopamine release in the nucleus accumbens are influenced by corticosterone. Eur. J. Neurosci. 1998, 10:3903.
29. Amato D., et al. Dynamic regulation of dopamine and serotonin responses to salient stimuli during chronic haloperidol treatment. Int. J. Neuropsychopharmacol. 2011, 14:1327.
30. Giorgi O., et al. Dissociation between mesocortical dopamine release and fear-related behaviours in two psychogenetically selected lines of rats that differ in coping strategies to aversive conditions. Eur. J. Neurosci. 2003, 17:2716.
31. Di Chiara G., et al. Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biol. Psychiatry 1999, 46:1624.
32. Budygin E.A., et al. Aversive stimulus differentially triggers subsecond dopamine release in reward regions. Neuroscience 2012, 201:331.
33. Park J., et al. Norepinephrine and dopamine transmission in 2 limbic regions differentially respond to acute noxious stimulation. Pain 2015, 156:318.
34. Lammel S., et al. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 2008, 57:760.
35. Wightman R.M., et al. Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur. J. Neurosci. 2007, 26:2046.
36. Apkarian A.V., et al. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 2005, 9:463.
37. Leknes S., Tracey I. A common neurobiology for pain and pleasure. Nat. Rev. Neurosci. 2008, 9:314.
38. Rushworth M.F., et al. Frontal cortex and reward-guided learning and decision-making. Neuron 2011, 70:1054.
39. Scott D.J., et al. Variations in the human pain stress experience mediated by ventral and dorsal basal ganglia dopamine activity. J. Neurosci. 2006, 26:10789.
40. Zubieta J.K., et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001, 293:311.
41. 11C]raclopride binding potential after a nonpharmacological challenge. Synapse 2007, 61:707.
42. Sprenger T., et al. Opioidergic activation in the medial pain system after heat pain. Pain 2006, 122:63.
43. Becerra L., Borsook D. Signal valence in the nucleus accumbens to pain onset and offset. Eur. J. Pain 2008, 12:866.
44. Baliki M.N., et al. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 2010, 66:149.
45. Mukamel R., et al. Coupling between neuronal firing, field potentials, and fMRI in human auditory cortex. Science 2005, 309:951.
46. Becerra L., et al. Analogous responses in the nucleus accumbens and cingulate cortex to pain onset (aversion) and offset (relief) in rats and humans. J. Neurophysiol. 2013, 110:1221.
47. Kuo C.C., Yen C.T. Comparison of anterior cingulate and primary somatosensory neuronal responses to noxious laser-heat stimuli in conscious, behaving rats. J. Neurophysiol. 2005, 94:1825.
48. Wang J.Y., et al. Morphine modulation of pain processing in medial and lateral pain pathways. Mol. Pain 2009, 5:60.
49. Yamamura H., et al. Morphological and electrophysiological properties of ACCx nociceptive neurons in rats. Brain Res. 1996, 735:83.
50. Bushnell M.C., et al. Cognitive and emotional control of pain and its disruption in chronic pain. Nat. Rev. Neurosci. 2013, 14:502.
51. Johansen J.P., Fields H.L. Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat. Neurosci. 2004, 7:398.
52. Surbey G.D., et al. Effects of naloxone on exercise performance. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 1984, 57:674.
53. Sgherza A.L., et al. Effect of naloxone on perceived exertion and exercise capacity during maximal cycle ergometry. J. Appl. Physiol. (1985) 2002, 93:2023.
54. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev. Neurosci. 2005, 6:533.
55. 11C]carfentanil. Neuroimage 2012, 61:670.
56. Lee M.C., et al. Imaging opioid analgesia in the human brain and its potential relevance for understanding opioid use in chronic pain. Neuropharmacology 2013, 84:123.
57. Wager T.D., et al. Placebo effects on human mu-opioid activity during pain. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11056.
58. Zubieta J.K., et al. Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. J. Neurosci. 2005, 25:7754.
59. Gerber B., et al. Pain-relief learning in flies, rats, and man: basic research and applied perspectives. Learn. Mem. 2014, 21:232.
60. Tanimoto H., et al. Experimental psychology: event timing turns punishment to reward. Nature 2004, 430:983.
61. Andreatta M., et al. Onset and offset of aversive events establish distinct memories requiring fear and reward networks. Learn. Mem. 2012, 19:518.
62. King T., et al. Contribution of afferent pathways to nerve injury-induced spontaneous pain and evoked hypersensitivity. Pain 2011, 152:1997.
63. King T., et al. Unmasking the tonic-aversive state in neuropathic pain. Nat. Neurosci. 2009, 12:1364.
64. Qu C., et al. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain 2011, 152:1641.
65. Davoody L., et al. Conditioned place preference reveals tonic pain in an animal model of central pain. J. Pain 2011, 12:868.
66. He Y., et al. Negative reinforcement reveals non-evoked ongoing pain in mice with tissue or nerve injury. J. Pain 2012, 13:598.
67. Okun A., et al. Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol. Pain 2011, 7:4.
68. Navratilova E., et al. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:20709.
69. Remeniuk B., et al. Behavioral and neurochemical analysis of ongoing bone cancer pain in rats. Pain 2015, 156:1864.
70. Liu P., et al. Ongoing pain in the MIA model of osteoarthritis. Neurosci. Lett. 2011, 493:72.
71. Okun A., et al. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 2012, 153:924.
72. Rauck R.L., et al. Intrathecal ziconotide for neuropathic pain: a review. Pain Pract. 2009, 9:327.
73. Andrieu G., et al. The efficacy of intrathecal morphine with or without clonidine for postoperative analgesia after radical prostatectomy. Anesth. Analg. 2009, 108:1954.
74. Lavand'homme P.M., et al. An evaluation of the postoperative antihyperalgesic and analgesic effects of intrathecal clonidine administered during elective Cesarean delivery. Anesth. Analg. 2008, 107:948.
75. Xie J.Y., et al. Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy. Pain 2014, 155:1659.
76. LaGraize S.C., et al. Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system. Exp. Neurol. 2006, 197:22.
77. Navratilova E., et al. Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain. J. Neurosci. 2015, 35:7264.
78. Fields H.L. A motivation-decision model of pain: the role of opioids. 11th World Congress on Pain 2006, 449-459. IASP Press. H. Flor (Ed.).
79. Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 2007, 30:259.
80. Murphy N.P. Dynamic measurement of extracellular opioid activity: status quo, challenges, and significance in rewarded behaviors. ACS Chem. Neurosci. 2015, 6:94.
81. Wightman R.M. Detection technologies. Probing cellular chemistry in biological systems with microelectrodes. Science 2006, 311:1570.
82. Baliki M., et al. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 2010, 66:149.
83. Westerink B.H. Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 1995, 70:103.
84. Stuart J.N., et al. The chemistry of thought: neurotransmitters in the brain. Anal. Chem. 2004, 76:121A.
85. Venton B.J., Wightman R.M. Psychoanalytical electrochemistry: dopamine and behavior. Anal. Chem. 2003, 75:414A.
86. Chefer V.I., et al. Overview of brain microdialysis. Curr. Protoc. Neurosci. 2009, 7. 7.1 (1-35).
87. Bucher E.S., Wightman R.M. Electrochemical analysis of neurotransmitters. Annu. Rev. Anal. Chem. (Palo Alto Calif.) 2015, 8:239.
88. Atcherley C.W., et al. The coaction of tonic and phasic dopamine dynamics. Chem. Commun. (Camb.) 2015, 51:2235.